It was reported that on (b)(6) 2018, a 25mm trifecta valve was successfully implanted.About 4 years later, the patient reported shortness of breath.In a scheduled appointment, it was determined that the patient had aortic insufficiency.On (b)(6) 2022, the device was explanted, and an unknown size epic plus valve was implanted as a replacement.There were leaflet tears and calcification on the explanted valve.The trifecta valve also showed incomplete coaptation after explant.The patient was reported as discharged.No additional information was provided.
|
Explant due to shortness of breath and aortic insufficiency was reported.The investigation found that all leaflets contained calcifications.Leaflets 2 and 3 were found torn.Leaflets 1 and 3 were found to have previous incisions.There was fibrous pannus ingrowth on the inflow surface of leaflet 1 and fibrous thickening on all leaflets.No inflammation was present.The device history record was reviewed to ensure that each manufacturing and inspection operation was performed and the product met all specifications.The cause of the tears could not be conclusively determined; however, the fibrous pannus ingrowth and calcifications noted had the potential to induce increased stress on adjacent leaflets and create an unbalanced stress relief distribution between all leaflets during coaptation, leading to leaflet tears and reduced durability.
|